APPLICATION
ANDA072418
TYPE
ANDA
ORIGINAL APPROVAL
1989-05-11
LATEST ACTION
2014-07-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
AMOXAPINEDiscontinued
AMOXAPINE 25MG · TABLET · ORAL
Approval history
2014-07-17Labeling · Supplement 15 · standardAP
2002-07-24Manufacturing (CMC) · Supplement 13AP
2001-10-05Labeling · Supplement 12AP
2001-09-05Manufacturing (CMC) · Supplement 11AP
1999-11-10Manufacturing (CMC) · Supplement 10AP
1997-08-01Manufacturing (CMC) · Supplement 9AP
1995-12-27Labeling · Supplement 8AP
1995-05-04Labeling · Supplement 7AP
1993-10-08Labeling · Supplement 6AP
1993-10-08Manufacturing (CMC) · Supplement 5AP
1992-06-02Labeling · Supplement 4AP
1991-01-17Labeling · Supplement 3AP
1991-01-07Manufacturing (CMC) · Supplement 2AP
1989-09-12Labeling · Supplement 1AP
1989-05-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.